Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07499258 · ClinicalTrials.gov registry record
Axonics R20 Post-Market Clinical Follow-up (PMCF) Study for the Indication of Fecal Incontinence
A clinical trial, sponsored by Axonics.
- Not yet
- Registry status
- 55
- Enrollment target
NCT07499258 is a clinical trial that has not yet begun recruiting, run by Axonics. The registered enrollment target is 55 participants.
The verdict
NCT07499258 has not yet begun recruiting, sponsored by Axonics.
- NOT YET RECRUITING
- Registry status
- 55 participants
- Enrollment target
Study Summary
Single-Arm, multi-center, prospective, open-label registry study for commercially available rechargeable implantable neurostimulator (INS model 5101); also referred to as R20.
Interventions
- DEVICE Axonics SNM System INS Model 5101 (R20)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2026-07 |
| Est. Completion | 2029-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07499258
The ClinicalTrials.gov registry entry for NCT07499258 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Axonics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Axonics SNM System INS Model 5101 (R20) is the first listed.
NCT07499258 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07499258 about?
NCT07499258 is a clinical study titled "Axonics R20 Post-Market Clinical Follow-up (PMCF) Study for the Indication of Fecal Incontinence". Single-Arm, multi-center, prospective, open-label registry study for commercially available rechargeable implantable neurostimulator (INS model 5101); also referred to as R20.
What is the current status of trial NCT07499258?
This trial is currently not yet recruiting. The enrollment target is 55 participants. The study started on 2026-07. Estimated completion is 2029-12.
What interventions are being tested in trial NCT07499258?
The interventions under investigation include: Axonics SNM System INS Model 5101 (R20) (DEVICE).
Who is sponsoring clinical trial NCT07499258?
This trial is sponsored by Axonics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.